Results from a new study showed people taking Wegovy (semaglutide) for weight loss were 33 percent less likely to die of COVID-19 than people taking placebo. They were also 15 percent less likely ...

Extreme hunger is common after people stop taking GLP-1 drugs like Ozempic and Wegovy, but health experts say these simple ...

If you buy through links on this page, we may earn a small commission. Here’s our process. Wegovy is a weight loss medication that you can only get with a prescription from a licensed healthcare ...

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday. Michael Siluk ...

The experimental medication has the potential to reduce hunger and slow stomach emptying even more so than drugs that are already on the market to treat obesity, like Wegovy. Novo Nordisk ...

Novo Nordisk’s oral obesity pill, amycretin, showed faster weight loss than its blockbuster weekly injection for chronic weight management, Wegovy (semaglutide), in the phase I study.

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new formulation ...

For nearly 3,400 patients with obesity, the average weight loss achieved with semaglutide (Wegovy and Ozempic) was more than twice that achieved with liraglutide (Saxenda and Victoza). Cleveland ...

Weight loss shots like Ozempic and Wegovy have been linked to 162 deaths in the United States over the past six years, according to the Daily Mail. These casualties are listed in the FDA’s FAERS ...

New Yorkers considering taking weight-loss drugs like Wegovy and Ozempic must navigate complex rules for public and private health insurance plans. At the same time, state lawmakers are debating ...